Trends in the Use of Anxiolytics in Castile and Leon, Spain, between 2015–2020
Evaluating the Impact of Covid-19
Bibliographic Data
| ID | 15467346 |
|---|---|
| Authors | Miryam Sánchez Díaz (0000-0002-7696-5736, Universidad de Salamanca, corresponding author), María Luisa Martín (0000-0003-4810-9673, Universidad de Salamanca), Ramona Mateos-Campos (0000-0002-0154-5761, Universidad de Salamanca) |
| Year | 2021 |
| Volume | 18 |
| Issue | 11 |
| Pages | 5944-5944 |
| Publication date | 2021-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph18115944 |
| PMID | 34205985 |
| OpenAlex | W3166592958 |
| Language | EN |
| Citations received | 4 |
| References cited | 9 |
Anxiolytics (N05B) are one of the most widely used pharmacological groups. This study aimed to analyze the progression of the consumption of anxiolytics (ATC classification: N05B) dispensed in pharmacies in Castile and Leon, Spain, from 2015 to 2020, with a special focus on the possible impact of COVID-19 on the use of these drugs. A quantitative-qualitative analysis of usage was carried out using the total number of packs and the packs per 1000 inhabitants. Overall, the use of anxiolytics grew by 14.41% during 2015-2020. The most commonly used drugs were the short-acting benzodiazepine derivatives lorazepam (whose use increased by 15.18%) and alprazolam (whose use increased by 21.40%), and the dispensing of the long-acting derivative diazepam increased the most, by 31.83%. Anxiolytics consumption increased significantly in 2020 and peaked in March. The pattern of use remained the same in 2020. The consumption of anxiolytics has continued to increase in Castile and Leon over the last six years. The COVID-19 pandemic situation affected the dispensing of these drugs, causing a sharp increase in prescriptions, especially during March, when the confinement of the population was initiated
Alprazolam · Anesthesia · Anxiety · Benzodiazepine · Coronavirus disease 2019 (COVID-19 · Defined daily dose · Diazepam · Environmental health · Lorazepam · Medical prescription · Pandemic · Population · Psychiatry · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · COVID-19 and Mental Health · Digital Mental Health Interventions · Medicine · Internal Medicine · Pharmacology
Consumption of hypnosedatives in Spain
Psychotropic consumption before and during Covid-19 in Asturias, Spain
Perfil de consumo de ansiolíticos e antidepressivos durante a pandemia de Covid-19 e as possíveis repercussões em saúde mental
Consumption of Psychiatric Drugs in Primary Care during the Covid-19 Pandemic
Immediate Psychological Effects of the Covid-19 Quarantine in Youth From Italy and Spain
Addressing collegiate mental health amid Covid-19 pandemic
Public responses to the novel 2019 coronavirus (2019‐nCoV) in Japan
Incremental validity of coronaphobia
How will country-based mitigation measures influence the course of the Covid-19 epidemic?
Mental health considerations for children quarantined because of Covid-19
Multidisciplinary research priorities for the Covid-19 pandemic
Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (Covid-19) Epidemic among the General Population in China
Depression and Anxiety in Hong Kong during Covid-19
| Unique citing works | 4 |
|---|---|
| Citations per year | 1 |
| Citation span | 2022 - 2024 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |